ArticleSignal transduction and targeted therapy2022

Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.

Yan-Xia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.